BR9305162A - Composto, formulação farmacêutica e processo para a preparação de um composto - Google Patents
Composto, formulação farmacêutica e processo para a preparação de um compostoInfo
- Publication number
- BR9305162A BR9305162A BR9305162A BR9305162A BR9305162A BR 9305162 A BR9305162 A BR 9305162A BR 9305162 A BR9305162 A BR 9305162A BR 9305162 A BR9305162 A BR 9305162A BR 9305162 A BR9305162 A BR 9305162A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparation
- pharmaceutical formulation
- chem
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99525692A | 1992-12-22 | 1992-12-22 | |
US08/134,329 US5733906A (en) | 1993-10-12 | 1993-10-12 | Inhibitors of HIV Protease useful for the treatment of Aids |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9305162A true BR9305162A (pt) | 1994-11-01 |
Family
ID=26832220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9305162A BR9305162A (pt) | 1992-12-22 | 1993-12-21 | Composto, formulação farmacêutica e processo para a preparação de um composto |
Country Status (21)
Country | Link |
---|---|
US (1) | US5905077A (pt) |
EP (1) | EP0604185B1 (pt) |
JP (1) | JPH06271534A (pt) |
KR (1) | KR940014337A (pt) |
CN (1) | CN1044117C (pt) |
AT (1) | ATE178055T1 (pt) |
AU (1) | AU667146B2 (pt) |
BR (1) | BR9305162A (pt) |
CA (1) | CA2112042A1 (pt) |
CZ (1) | CZ281493A3 (pt) |
DE (1) | DE69324120T2 (pt) |
ES (1) | ES2132201T3 (pt) |
FI (1) | FI935778A (pt) |
HU (1) | HUT69693A (pt) |
IL (1) | IL108092A (pt) |
MX (1) | MX9308016A (pt) |
MY (1) | MY131388A (pt) |
NO (1) | NO934719L (pt) |
NZ (1) | NZ250491A (pt) |
PL (1) | PL301581A1 (pt) |
TW (1) | TW262468B (pt) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USH1649H (en) | 1987-07-31 | 1997-05-06 | Barrish; Joel C. | HIV protease inhibitor combinations |
US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US5679688A (en) | 1992-03-11 | 1997-10-21 | Narhex Limited | Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5461154A (en) * | 1994-02-02 | 1995-10-24 | Eli Lilly And Company | Intermediate and process for making |
TW472047B (en) * | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
EP0710652B1 (en) * | 1994-11-04 | 1998-03-04 | Yamakawa Chemical Industry Co., Ltd. | Process for preparing optically active piperazine derivatives and intermediates for preparation |
WO1996023756A1 (fr) * | 1995-02-03 | 1996-08-08 | Kaneka Corporation | PROCEDES DE PRODUCTION D'α-HALOCETONES, D'α-HALOHYDRINES ET D'EPOXYDES |
US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
US5932550A (en) * | 1995-06-30 | 1999-08-03 | Japan Energy Corporation | Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
US6222043B1 (en) | 1995-06-30 | 2001-04-24 | Japan Energy Corporation | Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof |
ATE288891T1 (de) | 1995-09-26 | 2005-02-15 | Japan Tobacco Inc | Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen |
DE69637770D1 (de) * | 1995-09-26 | 2009-01-15 | Agouron Pharma | Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen |
ATE377006T1 (de) * | 1995-11-28 | 2007-11-15 | Cephalon Inc | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer |
US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
WO1998029118A1 (fr) | 1996-12-27 | 1998-07-09 | Japan Energy Corporation | Nouveaux composes de tripeptides et medicaments anti-sida |
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
ATE344050T1 (de) | 1997-03-14 | 2006-11-15 | Daiichi Seiyaku Co | Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung |
WO2000002862A1 (en) * | 1998-07-08 | 2000-01-20 | G.D. Searle & Co. | Retroviral protease inhibitors |
HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
NZ509241A (en) | 1998-08-07 | 2003-08-29 | Du Pont Pharm Co | Succinoylamino lactams as inhibitors of alpha-beta protein production |
IL142816A0 (en) | 1998-12-24 | 2002-03-10 | Du Pont Pharm Co | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
US6960576B2 (en) * | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
CA2384544A1 (en) | 1999-10-08 | 2001-04-19 | Bristol-Myers Squibb Pharma Company | Amino lactam sulfonamides as inhibitors of a.beta. protein production |
US6525044B2 (en) | 2000-02-17 | 2003-02-25 | Bristol-Myers Squibb Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production |
US6495540B2 (en) | 2000-03-28 | 2002-12-17 | Bristol - Myers Squibb Pharma Company | Lactams as inhibitors of A-β protein production |
CA2403550A1 (en) | 2000-04-03 | 2001-10-11 | Hong Liu | Cyclic lactams as inhibitors of a-.beta. protein production |
CN1436175A (zh) | 2000-04-03 | 2003-08-13 | 布里斯托尔-迈尔斯斯奎布药品公司 | 作为Aβ-蛋白生产抑制剂的环状内酰胺 |
EP1289966A1 (en) * | 2000-04-11 | 2003-03-12 | Bristol-Myers Squibb Pharma Company | SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
US20100009966A1 (en) * | 2001-04-11 | 2010-01-14 | Bristol-Myers Squibb Pharma Company | Substituted lactams as inhibitors of abeta protein production |
US6878363B2 (en) * | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
US6509333B2 (en) * | 2000-06-01 | 2003-01-21 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of Aβ protein production |
GB0028483D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Hydroxyethylamine HIV protease inhibitors |
JPWO2002064553A1 (ja) * | 2001-02-14 | 2004-06-10 | 呉羽化学工業株式会社 | ハロゲノアルコール誘導体の製造方法 |
US20090062256A1 (en) * | 2001-06-01 | 2009-03-05 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
GB0123467D0 (en) | 2001-09-28 | 2001-11-21 | Hoffmann La Roche | Carbocyclic HIV Protease inhibitors |
KR101155335B1 (ko) * | 2005-01-07 | 2012-06-11 | 엘지전자 주식회사 | 이동통신 단말기의 멀티미디어 메시지 동작방법 |
EP1910317B1 (en) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | 1-amino linked compounds |
CN101508664B (zh) * | 2009-02-25 | 2012-08-22 | 江阴希迪医药科技有限公司 | N-苄氧羰基-3-氨基-1-氯-4-苯硫基-2-丁醇合成方法 |
BR112012033689A2 (pt) | 2010-07-02 | 2019-09-24 | Gilead Sciences Inc | derivados de ácido 2-quinolinil-acético como compostos de hiv antivirais |
JP5984218B2 (ja) | 2010-07-02 | 2016-09-06 | ギリアード サイエンシーズ, インコーポレイテッド | Aidsを処置するためのナフト−2−イル酢酸誘導体 |
ES2707997T3 (es) | 2011-04-21 | 2019-04-08 | Gilead Sciences Inc | Compuestos de benzotiazol y su uso farmacéutico |
WO2013103724A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
WO2013103738A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
RU2014115227A (ru) | 2012-04-20 | 2015-10-27 | Джилид Сайэнс, Инк. | Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
EP0813867B1 (en) * | 1990-11-19 | 2005-06-01 | Monsanto Company | Retroviral protease inhibitors |
HUT60282A (en) * | 1991-02-08 | 1992-08-28 | Sankyo Co | Process for producing new beta-amino-alpha-hydroxycarboxylic acid derivatives and pharmaceutical compositions comprising such compounds |
US5430041A (en) * | 1991-05-10 | 1995-07-04 | Hoffmann-La Roche Inc. | Amino acid derivatives having antiviral activity |
CN1071930A (zh) | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
ZA929869B (en) | 1991-12-20 | 1994-06-20 | Syntex Inc | Hiv protease inhibitors |
US5312820A (en) * | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
-
1993
- 1993-12-15 MX MX9308016A patent/MX9308016A/es not_active IP Right Cessation
- 1993-12-17 NZ NZ250491A patent/NZ250491A/en unknown
- 1993-12-17 MY MYPI93002745A patent/MY131388A/en unknown
- 1993-12-17 CZ CZ932814A patent/CZ281493A3/cs unknown
- 1993-12-20 HU HU9303679A patent/HUT69693A/hu unknown
- 1993-12-20 PL PL93301581A patent/PL301581A1/xx unknown
- 1993-12-20 IL IL108092A patent/IL108092A/en active IP Right Grant
- 1993-12-20 AT AT93310359T patent/ATE178055T1/de not_active IP Right Cessation
- 1993-12-20 AU AU52528/93A patent/AU667146B2/en not_active Ceased
- 1993-12-20 NO NO934719A patent/NO934719L/no unknown
- 1993-12-20 ES ES93310359T patent/ES2132201T3/es not_active Expired - Lifetime
- 1993-12-20 DE DE69324120T patent/DE69324120T2/de not_active Expired - Fee Related
- 1993-12-20 EP EP93310359A patent/EP0604185B1/en not_active Expired - Lifetime
- 1993-12-21 FI FI935778A patent/FI935778A/fi not_active Application Discontinuation
- 1993-12-21 CA CA002112042A patent/CA2112042A1/en not_active Abandoned
- 1993-12-21 CN CN93112962A patent/CN1044117C/zh not_active Expired - Fee Related
- 1993-12-21 JP JP5322750A patent/JPH06271534A/ja active Pending
- 1993-12-21 BR BR9305162A patent/BR9305162A/pt not_active Application Discontinuation
- 1993-12-22 TW TW082110893A patent/TW262468B/zh active
- 1993-12-22 KR KR1019930029121A patent/KR940014337A/ko active IP Right Grant
-
1997
- 1997-11-19 US US08/974,430 patent/US5905077A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1044117C (zh) | 1999-07-14 |
DE69324120T2 (de) | 1999-11-25 |
IL108092A (en) | 1998-06-15 |
CN1094399A (zh) | 1994-11-02 |
MY131388A (en) | 2007-08-30 |
JPH06271534A (ja) | 1994-09-27 |
KR940014337A (ko) | 1994-07-18 |
TW262468B (pt) | 1995-11-11 |
HUT69693A (en) | 1995-09-28 |
NO934719D0 (no) | 1993-12-20 |
AU667146B2 (en) | 1996-03-07 |
ATE178055T1 (de) | 1999-04-15 |
PL301581A1 (en) | 1994-06-27 |
FI935778A0 (fi) | 1993-12-21 |
EP0604185B1 (en) | 1999-03-24 |
IL108092A0 (en) | 1994-04-12 |
US5905077A (en) | 1999-05-18 |
CZ281493A3 (en) | 1994-07-13 |
EP0604185A1 (en) | 1994-06-29 |
DE69324120D1 (de) | 1999-04-29 |
FI935778A (fi) | 1994-06-23 |
ES2132201T3 (es) | 1999-08-16 |
MX9308016A (es) | 1994-08-31 |
CA2112042A1 (en) | 1994-06-23 |
AU5252893A (en) | 1994-07-07 |
NO934719L (no) | 1994-06-23 |
NZ250491A (en) | 1995-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9305162A (pt) | Composto, formulação farmacêutica e processo para a preparação de um composto | |
DZ1467A1 (fr) | Dérivés d'acides amines. | |
DE69334250D1 (de) | Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern | |
BR9305164A (pt) | Composto, formulação farmacêutica e processo para preparar um composto | |
DK0810209T3 (da) | Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser | |
CZ284872B6 (cs) | Cyklické močoviny a jejich analogy a farmaceutické přípravky na jejich bázi | |
GR3022604T3 (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
DK0823254T3 (da) | Hidtil ukendt anvendelse af pyrazolopyridinforbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
HKFN | Application deemed withdrawn (deleted) | ||
FA7 | Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health |